| Ms Myra Khan, DO | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Ms Myra Khan |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 10 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588075162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 5101025342 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Javon Bea Hospital | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockford Health Physicians | 2567374036 | 289 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE).
Emergency department physicians who saw patients with a pulmonary embolism-;a blood clot in the lung-;were about 15% likelier over the next 10 days to test subsequent patients for the same thing.
A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
› Verified 2 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE).
Emergency department physicians who saw patients with a pulmonary embolism-;a blood clot in the lung-;were about 15% likelier over the next 10 days to test subsequent patients for the same thing.
A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
› Verified 2 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031111000307 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE).
Emergency department physicians who saw patients with a pulmonary embolism-;a blood clot in the lung-;were about 15% likelier over the next 10 days to test subsequent patients for the same thing.
A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Myra Khan, DO 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Ms Myra Khan, DO 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced preliminary data from its ongoing open-label Phase 1/2 clinical trial of SAGE-547, an allosteric modulator of GABAA receptors, in patients with super-refractory status epilepticus (SRSE).
Emergency department physicians who saw patients with a pulmonary embolism-;a blood clot in the lung-;were about 15% likelier over the next 10 days to test subsequent patients for the same thing.
A genetic disorder called neurofibromatosis (NF) causes benign tumors to grow on the brain, spinal cord, and other parts of the nervous system.
We need death panels. Well, maybe not death panels, exactly, but unless we start allocating health care resources more prudently - rationing, by its proper name - the exploding cost of Medicare will swamp the federal budget.
The creatinine clearance (Ccr) test has been used as a gold standard for evaluation of preoperative renal function in patients with gastric cancer. However, it is known that Ccr is not strictly equivalent to glomerular filtration rate (GFR). It has been accepted that estimated GFR (eGFR) is equal to measured GFR in chronic kidney disease. However, there have been no studies regarding the reliability of eGFR as a preoperative renal function test in gastric cancer patients.
› Verified 2 days ago
Nathanael Bailey, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, 2nd Floor University Hospital Recp Pathology, Ann Arbor, MI 48109 Phone: 800-862-7284 | |
Lokman Sung, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1500 E Medical Center Dr, 2nd Floor University Hospital Recp Pathology, Ann Arbor, MI 48109 Phone: 800-862-7284 | |
Dr. Hong Cheng, MD, PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3426 Braeburn Cir, Ann Arbor, MI 48108 Phone: 734-972-1481 | |
Kyle David Perry, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Asma Nusrat, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Drive, 2nd Floor University Hospital Recp Pathology, Ann Arbor, MI 48109 Phone: 800-862-7284 | |
Dr. James Albert Ramirez, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3131 S State St Ste 309, Ann Arbor, MI 48108 Phone: 503-906-7300 Fax: 503-245-8219 | |
Douglas Smith, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 2nd Floor University Hospital Recp Pathology, Ann Arbor, MI 48109 Phone: 800-862-7284 |